Related Experiment Video
Updated: Feb 15, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
A study on the contamination of injection bevacizumab on storage of multidose vials
Ketan Saoji1, Hemant Trehan1, Raja Narayanan1
1Department of Ophthalmology, INHS Asvini, Mumbai, Maharashtra, India.
Purpose:
The aim of this study is to establish the safety of storage and reuse of bevacizumab vials for 1 week with multiple vial punctures.
Methods:
This was an experimental microbiological study conducted at tertiary care hospital. The study samples included bevacizumab vials that had been used for injecting patients by the pooling method. Vials were stored and sampled in a manner that replicated their proposed clinical use. Contamination of vials was evaluated on the basis of microbial culture and validated by positive and negative controls. The probability of obtaining such results purely by chance was calculated.
Results:
A total of 210 samples from 30 vials were evaluated along with 210 positive and 210 negative controls. No growth was seen in any of the bevacizumab samples. The probability of obtaining 210 consecutive sterile samples just by chance is <5.547 × 10-6 (0.000005547).
Conclusion:
The vials showed no contamination on storage for 7 days in an ordinary refrigerator. Thus, we conclude that the rate of contamination of bevacizumab vials on storage for 7 days in a refrigerator is likely to be insignificant. The results need to be validated by other studies replicating this protocol.
Insights
Bevacizumab vials can be safely stored and reused for one week after multiple punctures, showing no contamination. This finding suggests insignificant contamination rates for bevacizumab vials stored in a refrigerator.
Area of Science:
- Microbiology
- Oncology
- Ophthalmology
Background:
- Bevacizumab is an anti-VEGF monoclonal antibody used in oncology and ophthalmology.
- The safety of storing and reusing bevacizumab vials after multiple punctures is a critical concern for clinical practice.
Purpose of the Study:
- To determine the safety of storing and reusing bevacizumab vials for up to one week with multiple punctures.
- To assess the microbiological contamination risk associated with such practices.
Main Methods:
- An experimental microbiological study was conducted using bevacizumab vials after patient injections.
- Vials were stored and sampled to mimic clinical reuse, with contamination assessed via microbial culture.
- Positive and negative controls were used, and statistical analysis calculated the probability of contamination by chance.
Main Results:
- A total of 210 samples from 30 bevacizumab vials were tested.
- No microbial growth was observed in any of the bevacizumab samples.
- The probability of achieving 210 sterile samples purely by chance was extremely low (<5.547 × 10-6).
Conclusions:
- Bevacizumab vials showed no contamination after 7 days of storage in a standard refrigerator.
- The rate of contamination for bevacizumab vials stored for 7 days is likely insignificant.
- Further studies are recommended to validate these findings using the same protocol.
Related Concept Videos
Storage
Contaminants and Errors
Another key consideration is determining the appropriate number of samples required to...
ATP Energy Storage and Release
One example of energy coupling using ATP involves a...
Sugars as Energy Storage Molecules
Fats as Energy Storage Molecules
Case Studies

